Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VU, JAKE MINH | 1 | 40.5% | +27.6% |
| HILL, MYRON G | 1 | 66.5% | +19.8% |
| SONG, JIANFENG | 1 | 56.1% | +33.5% |
| JOHNSON, ALLISON MARIE | 1 | 45.7% | +50.0% |
| KELLY, ROBERT M | 1 | 74.1% | +24.6% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 36.4% | +70.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015575 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | SONG, JIANFENG | 105d overdue |
| 19063950 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | VU, JAKE MINH | 73d overdue |
| 17430341 | MODULATION OF REP PROTEIN ACTIVITY IN CLOSED-ENDED DNA (CEDNA) PRODUCTION | LIPPOLIS, ALEXANDRA ROSE | 31d overdue |
| 17913477 | NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FACTOR IX THERAPEUTICS | JOHNSON, ALLISON MARIE | 23d overdue |
| 17913482 | NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERAPEUTICS | KELLY, ROBERT M | 16d overdue |
| 18289622 | NON-VIRAL DNA VECTORS FOR VACCINE DELIVERY | HILL, MYRON G | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1618 | 1 |
| 1671 | 1 |
| 1613 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19063950 | STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING | VU, JAKE MINH | 1618 | §103 | Non-Final OA | 73d overdue | Pending | Feb 26, 2025 |
| 18289622 | NON-VIRAL DNA VECTORS FOR VACCINE DELIVERY | HILL, MYRON G | 1671 | §103 | Non-Final OA | 4d overdue | Pending | Nov 06, 2023 |
| 18015575 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | SONG, JIANFENG | 1613 | Other | Non-Final OA | 105d overdue | Pending | Jan 11, 2023 |
| 17913477 | NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING FACTOR IX THERAPEUTICS | JOHNSON, ALLISON MARIE | 1638 | Other | Non-Final OA | 23d overdue | Pending | Sep 22, 2022 |
| 17913482 | NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERAPEUTICS | KELLY, ROBERT M | 1638 | §103 | Non-Final OA | 16d overdue | Pending | Sep 22, 2022 |
| 17430341 | MODULATION OF REP PROTEIN ACTIVITY IN CLOSED-ENDED DNA (CEDNA) PRODUCTION | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Non-Final OA | 31d overdue | Pending | Aug 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial